Skip to main content

Table 4 Association between increase of heart rate during endotracheal suctioning and poor functional 3-month outcome

From: Hemodynamic response during endotracheal suctioning predicts awakening and functional outcome in subarachnoid hemorrhage patients

 

Adjusted for midazolam dose (model 1)

Adjusted for RASS* (model 2)

Variables

AdjOR, 95% CI

p value

AdjOR, 95%-CI

p value

∆HR [bpm]

0.96, 0.94–0.98

< 0.001

0.95, 0.93–0.98

< 0.001

Age [years]

1.06, 1.05–1.07

< 0.001

1.06, 1.05–1.07

< 0.001

H&H grade

1.86, 1.65–2.09

< 0.001

1.95, 1.72–2.22

< 0.001

Absolute HR [bpm]

1.02, 1.01–1.03

0.003

1.02, 1.01–1.03

< 0.001

Daily cumulative dobutamine dose [mg]

0.998, 0.997–0.999

0.001

0.998, 0.997–0.999

< 0.001

Daily cumulative noradrenaline dose [mg]

0.99, 0.98–1.00

0.173

0.99, 0.97–0.998

0.028

Daily cumulative sufentanil dose [μg]

1.00, 1.00–1.00

0.074

1.00, 1.00–1.00

0.037

Daily cumulative midazolam dose [mg]

1.00, 0.99–1.00

0.344

–

–

RASS

–

–

0.70, 0.50–0.98

0.040

  1. *One hundred seventy-nine patients were included due to missing RASS recordings
  2. ∆HR change of heart rate during suctioning, H&H Hunt and Hess, RASS Richmond Agitation Sedation Scale, adjOR adjusted odds ratio, CI confidence interval